NuScale Power faces securities lawsuit over ENTRA1 partnership claims

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

NuScale Power faces securities lawsuit alleging material misrepresentations about ENTRA1 partnership synergies. Class action targets investors who purchased shares May-November 2025.

NuScale Power faces securities lawsuit over ENTRA1 partnership claims

A securities class action lawsuit has been filed against NuScale Power Corporation, alleging that company defendants made material misrepresentations regarding projected synergies from a global commercialization partnership with ENTRA1 Energy LLC. The lawsuit targets investors who purchased NuScale shares during the period from May 13, 2025 through November 6, 2025, a timeframe that encompasses the announcement and initial development of the strategic partnership.

The legal action centers on claims that the defendants provided misleading statements or omissions concerning the potential benefits and financial impact of the partnership arrangement. Investors who experienced losses during the specified period may have grounds to participate in the litigation, with a lead plaintiff deadline established for April 20, 2026. Legal counsel Bernstein Liebhard LLP is coordinating the case and has indicated willingness to discuss potential claims with affected investors.

Affected investors are advised to review the details of the lawsuit and consult with legal representatives to determine their eligibility and options. The case remains in its early stages, and the outcome may have implications for shareholder recovery and corporate disclosure standards within the small modular reactor industry.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 19

Related Coverage

GlobeNewswire Inc.

Plug Power Faces Class Action Over DOE Loan Claims as April Deadline Looms

Plug Power faces class action lawsuit alleging false statements about DOE loans and hydrogen facilities. Investors have until April 3, 2026 to apply as lead plaintiffs.

PLUG
GlobeNewswire Inc.

BlackRock TCP Capital Hit by Class Action Over $19B NAV Collapse

BlackRock TCP Capital faces class action lawsuit after 19% NAV decline and 12.97% stock plunge. Investors must act by April 6 deadline.

TCPC
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
GlobeNewswire Inc.

Class Action Lawsuit Filed Against China Liberal Education Over Alleged $300M Pump-and-Dump Scheme

Class action lawsuit filed against China Liberal Education Holdings for alleged pump-and-dump scheme coordinating with scammers, resulting in $300M+ investor losses.

CLEUF
GlobeNewswire Inc.

METC Faces Class Action Over Brook Mine Claims; Lead Plaintiff Deadline Set for March 31

Ramaco Resources faces class action lawsuit over alleged false Brook Mine operational claims, with lead plaintiff deadline set for March 31, 2026.

METCMETCBMETCI
GlobeNewswire Inc.

Disc Medicine Stock Collapses on FDA Rejection; Law Firm Probes Securities Fraud

Pomerantz LLP investigates Disc Medicine ($IRON) for potential securities fraud after FDA rejected bitopertin drug application, triggering consecutive stock declines totaling over 28%.

IRON